A retrospective pooled biomarker study to predict overall survival beyond the TNM system

K. G. Jebsen Colorectal Cancer Research Centre scientists participated with data from patients admitted to Oslo University Hospital in a multicenter study of >7000 stage II and III CRC recently reported in Annals of Oncology, Dienstmann et al., March.

Researchers Stine Aske Danielsen and Anita Sveen